0001209191-19-057143.txt : 20191119 0001209191-19-057143.hdr.sgml : 20191119 20191119161531 ACCESSION NUMBER: 0001209191-19-057143 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191118 FILED AS OF DATE: 20191119 DATE AS OF CHANGE: 20191119 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GARDINER SANDRA A. CENTRAL INDEX KEY: 0001218574 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37744 FILM NUMBER: 191231354 MAIL ADDRESS: STREET 1: CUTERA, INC. STREET 2: 3240 BAYSHORE BOULEVARD CITY: BRISBANE STATE: CA ZIP: 94005 FORMER NAME: FORMER CONFORMED NAME: GARDINER SANDRA DATE OF NAME CHANGE: 20030212 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Pulse Biosciences, Inc. CENTRAL INDEX KEY: 0001625101 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 465696597 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3957 POINT EDEN WAY CITY: HAYWARD STATE: CA ZIP: 94545 BUSINESS PHONE: 510-906-4600 MAIL ADDRESS: STREET 1: 3957 POINT EDEN WAY CITY: HAYWARD STATE: CA ZIP: 94545 FORMER COMPANY: FORMER CONFORMED NAME: Electroblate, Inc. DATE OF NAME CHANGE: 20141113 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-11-18 0 0001625101 Pulse Biosciences, Inc. PLSE 0001218574 GARDINER SANDRA A. 3957 POINT EDEN WAY HAYWARD CA 94545 0 1 0 0 CFO & EVP Admin. and Finance Stock Option (right to buy) 13.94 2019-11-18 4 A 0 103842 0.00 A 2020-11-18 2029-11-18 Common Stock 103842 103842 D Stock Option (right to buy) 13.94 2019-11-18 5 A 0 E 103842 0.00 A 2029-11-18 Common Stock 103842 103842 D The shares subject to the option will vest in equal annual installments over the following four years on the anniversary of the grant date, subject to the Reporting Person's continued service through each vesting date. The shares subject to the option shall vest based upon the achievement of performance objectives, with vesting targets set no less than one-fourth (1/4) vesting per year upon achievement of said objectives established by the Compensation Committee of the Issuer, subject to the Reporting Person's continued service through each vesting date. If performance objectives are not set by the Compensation Committee, the shares subject to the option will vest in equal annual installments over the following four years on the anniversary of the grant date, subject to the Reporting Person's continued service through each vesting date. /s/ Darrin R. Uecker, as Attorney-in-Fact 2019-11-19